Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
株式のランク #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
株価
$5.59
最終同期: 2026-09-02
時価総額
$205.21M
変化(1日)
6.27%
変化(1年)
86.33%
US
取引 Armata Pharmaceuticals, Inc. (ARMP)

カテゴリー

Armata Pharmaceuticals, Inc.(ARMP)の株式分割履歴
Armata Pharmaceuticals, Inc.株(シンボル:ARMP)は合計で0回の株式分割を実施しました。
最新の株式分割はSep 03, 2026に行われました。
Sep 03, 2026より前に購入されたARMP株は、現在0ARMP株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH